Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk
Clinical trial NCT01764633 · COMPLETED
Trial details
- NCT number
- NCT01764633
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-08
- Primary completion
- 2016-11-11
- Enrollment
- 27564
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.